Disease specificity of kinase domains

The src-encoded catalytic domain converts erbB into a sarcoma oncogene

Chi Ming Chang, Hui Kuo G. Shu, Hsing Jien Kung

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

src and erbB are two tyrosine kinase-encoding oncogenes carried by retroviruses, which have distinct disease specificities. The former induces predominantly sarcomas, and the latter, leukemias. Src and ErbB have similar catalytic domains but have very different regulatory domains. A wealth of information exists concerning how different regulatory domains [Src homology 2 (SH2) and SH3 domains and autophosphorylation sites] control substrate and disease specificities. Whether the catalytic domain helps determine these specificities remains to be explored. Here we show that the Src catalytic domain is enzymatically active when substituted into the ErbB backbone and interacts with the ErbB regulatory domain. This ErbB/Src chimera displays autophosphorylation and substrate phosphorylation patterns different from those of both Src and ErbB. Neither SH2 and SH3 nor autophosphorylation sites are required for the Src catalytic domain to exert its fibroblast transforming ability. Most significantly, the catalytic domain can convert erbB from a leukemogenic oncogene into a sarcomagenic oncogene, suggesting that the leukemogenic determinants in part reside within the ErbB catalytic domain.

Original languageEnglish
Pages (from-to)3928-3932
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume92
Issue number9
DOIs
Publication statusPublished - Apr 25 1995
Externally publishedYes

Fingerprint

Oncogenes
Sarcoma
Catalytic Domain
Phosphotransferases
src Homology Domains
Retroviridae
Substrate Specificity
Protein-Tyrosine Kinases
Leukemia
Fibroblasts
Phosphorylation

Keywords

  • erythroleukemia
  • receptor tyrosine kinase
  • retroviruses
  • viral oncogenesis

ASJC Scopus subject areas

  • General

Cite this

@article{8d7f71be2af3402eb7d067e012ca33b9,
title = "Disease specificity of kinase domains: The src-encoded catalytic domain converts erbB into a sarcoma oncogene",
abstract = "src and erbB are two tyrosine kinase-encoding oncogenes carried by retroviruses, which have distinct disease specificities. The former induces predominantly sarcomas, and the latter, leukemias. Src and ErbB have similar catalytic domains but have very different regulatory domains. A wealth of information exists concerning how different regulatory domains [Src homology 2 (SH2) and SH3 domains and autophosphorylation sites] control substrate and disease specificities. Whether the catalytic domain helps determine these specificities remains to be explored. Here we show that the Src catalytic domain is enzymatically active when substituted into the ErbB backbone and interacts with the ErbB regulatory domain. This ErbB/Src chimera displays autophosphorylation and substrate phosphorylation patterns different from those of both Src and ErbB. Neither SH2 and SH3 nor autophosphorylation sites are required for the Src catalytic domain to exert its fibroblast transforming ability. Most significantly, the catalytic domain can convert erbB from a leukemogenic oncogene into a sarcomagenic oncogene, suggesting that the leukemogenic determinants in part reside within the ErbB catalytic domain.",
keywords = "erythroleukemia, receptor tyrosine kinase, retroviruses, viral oncogenesis",
author = "Chang, {Chi Ming} and Shu, {Hui Kuo G.} and Kung, {Hsing Jien}",
year = "1995",
month = "4",
day = "25",
doi = "10.1073/pnas.92.9.3928",
language = "English",
volume = "92",
pages = "3928--3932",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "9",

}

TY - JOUR

T1 - Disease specificity of kinase domains

T2 - The src-encoded catalytic domain converts erbB into a sarcoma oncogene

AU - Chang, Chi Ming

AU - Shu, Hui Kuo G.

AU - Kung, Hsing Jien

PY - 1995/4/25

Y1 - 1995/4/25

N2 - src and erbB are two tyrosine kinase-encoding oncogenes carried by retroviruses, which have distinct disease specificities. The former induces predominantly sarcomas, and the latter, leukemias. Src and ErbB have similar catalytic domains but have very different regulatory domains. A wealth of information exists concerning how different regulatory domains [Src homology 2 (SH2) and SH3 domains and autophosphorylation sites] control substrate and disease specificities. Whether the catalytic domain helps determine these specificities remains to be explored. Here we show that the Src catalytic domain is enzymatically active when substituted into the ErbB backbone and interacts with the ErbB regulatory domain. This ErbB/Src chimera displays autophosphorylation and substrate phosphorylation patterns different from those of both Src and ErbB. Neither SH2 and SH3 nor autophosphorylation sites are required for the Src catalytic domain to exert its fibroblast transforming ability. Most significantly, the catalytic domain can convert erbB from a leukemogenic oncogene into a sarcomagenic oncogene, suggesting that the leukemogenic determinants in part reside within the ErbB catalytic domain.

AB - src and erbB are two tyrosine kinase-encoding oncogenes carried by retroviruses, which have distinct disease specificities. The former induces predominantly sarcomas, and the latter, leukemias. Src and ErbB have similar catalytic domains but have very different regulatory domains. A wealth of information exists concerning how different regulatory domains [Src homology 2 (SH2) and SH3 domains and autophosphorylation sites] control substrate and disease specificities. Whether the catalytic domain helps determine these specificities remains to be explored. Here we show that the Src catalytic domain is enzymatically active when substituted into the ErbB backbone and interacts with the ErbB regulatory domain. This ErbB/Src chimera displays autophosphorylation and substrate phosphorylation patterns different from those of both Src and ErbB. Neither SH2 and SH3 nor autophosphorylation sites are required for the Src catalytic domain to exert its fibroblast transforming ability. Most significantly, the catalytic domain can convert erbB from a leukemogenic oncogene into a sarcomagenic oncogene, suggesting that the leukemogenic determinants in part reside within the ErbB catalytic domain.

KW - erythroleukemia

KW - receptor tyrosine kinase

KW - retroviruses

KW - viral oncogenesis

UR - http://www.scopus.com/inward/record.url?scp=0029003457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029003457&partnerID=8YFLogxK

U2 - 10.1073/pnas.92.9.3928

DO - 10.1073/pnas.92.9.3928

M3 - Article

VL - 92

SP - 3928

EP - 3932

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -